Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
1,389
datasets available to search
ShareScore release 0.9.0
Dataset results
1,389 results for “Bladder cancer”
Chemoablation for Low-Grade Bladder Cancer
ClinicalTrials.gov study NCT07019220. IPD Sharing: NO. Countries: 1. Publications: 6.
Pembrolizumab-Epacadostat Combination to Treat Muscle-invasive Bladder UrotheLIAl canceR: PECULIAR Study
ClinicalTrials.gov study NCT03832673. IPD Sharing: NO. Countries: 1. Publications: 16.
Peptide Vaccine Focusing on Prevention of the Recurrence for Bladder Cancer
ClinicalTrials.gov study NCT00633204. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Adjuvant Radiotherapy After Cystectomy for Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT02397434. IPD Sharing: Not stated. Countries: 1. Publications: 1.
To Evaluate the Safety, Efficacy, and Pharmacokinetics of Intravesical Instiliations of Disitamab Vedotin in Patients With High-risk Non-muscular Invasive Bladder Cancer (NMIBC) That Express HER2
ClinicalTrials.gov study NCT06378242. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Trial With Vinflunine in Patients With Metastatic Bladder Cancer and Impaired Renal Function
ClinicalTrials.gov study NCT02665039. IPD Sharing: NO. Countries: 2. Publications: 1.
Comparison of BCG RIVM and Russian Strains for Treating Non-Muscle-Invasive Bladder Cancer (NMIBC)
ClinicalTrials.gov study NCT06767982. IPD Sharing: YES. Countries: 1. Publications: 5.
Combined Use of BCG and Interferon Alpha in Bladder Cancer
ClinicalTrials.gov study NCT00330707. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Role of NAC in cT0 Muscle-invasive Bladder Cancer After Maximal TURBt
ClinicalTrials.gov study NCT05776758. IPD Sharing: NO. Countries: 1. Publications: 11.
Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
ClinicalTrials.gov study NCT06493370. IPD Sharing: Not stated. Countries: 1. Publications: 36.
Neoadjuvant Chemotherapy in Locally Advanced Bladder Cancer
ClinicalTrials.gov study NCT01801644. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Pembrolizumab-Sacituzumab Govitecan Combination to Treat High-risk, Localized Bladder Cancer
ClinicalTrials.gov study NCT05535218. IPD Sharing: NO. Countries: 1. Publications: 0.
The Effect of the COVID-19 Pandemic on Primary Bladder Cancer Presentations
ClinicalTrials.gov study NCT04900259. IPD Sharing: NO. Countries: 1. Publications: 3.
Paclitaxel in Treating Patients With Early-Stage Bladder Cancer
ClinicalTrials.gov study NCT00002917. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effect of Bladder Distension on Dosimetry in Brachytherapy of Cervical Cancer
ClinicalTrials.gov study NCT02865837. IPD Sharing: NO. Countries: 1. Publications: 0.
Radiation Therapy, Chemotherapy, or Observation in Treating Patients With Bladder Cancer
ClinicalTrials.gov study NCT00002490. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase II Study of Atezolizumab in Combination With Cisplatin + Gemcitabine Before Surgery to Remove the Bladder Cancer
ClinicalTrials.gov study NCT02989584. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety and Tolerability of GemRIS 225 mg in Subjects With Muscle-Invasive Bladder Cancer
ClinicalTrials.gov study NCT02722538. IPD Sharing: Not stated. Countries: 2. Publications: 1.
Optimized Treatment Strategy for HighGrade1 (HGT1) Bladder Cancer Based on Substaging: a Prospective Observational Cohort Study
ClinicalTrials.gov study NCT02113501. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Phase 2 Study of Docetaxel +/- OGX-427 in Patients With Relapsed or Refractory Metastatic Bladder Cancer
ClinicalTrials.gov study NCT01780545. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.